The utility of 99mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidism

2010 ◽  
Vol 180 (1) ◽  
pp. 191-194 ◽  
Author(s):  
N. Glynn ◽  
N. Lynn ◽  
C. Donagh ◽  
R. K. Crowley ◽  
D. Smith ◽  
...  
2010 ◽  
Vol 395 (7) ◽  
pp. 929-933 ◽  
Author(s):  
Joaquin Gómez-Ramírez ◽  
Juan Jose Sancho-Insenser ◽  
Jose Antonio Pereira ◽  
Jaime Jimeno ◽  
Assumpta Munné ◽  
...  

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A266-A267
Author(s):  
Timur Gusov ◽  
John Chen Liu ◽  
Sowjanya Naha ◽  
F N U Marium ◽  
Joseph Theressa Nehu Parimi ◽  
...  

Abstract Primary hyperparathyroidism (PHPT) is defined as excessive secretion of parathyroid hormone (PTH) originating from the parathyroid gland. The most common cause is a single parathyroid adenoma which is typically solid. Cystic parathyroid adenomas (CPA) are the cause of about 1–2% of cases of primary hyperparathyroidism. It is known that cystic parathyroid adenomas are a result of degeneration of an existing parathyroid adenoma. SestaMIBI is an imaging study based on uptake of radioactive technetium99 and used to localize parathyroid adenomas. We describe an unusual case of severe hypercalcemia secondary to 99mTc sestaMIBI negative atypical parathyroid cystic adenoma. A 56-year-old male presented to our facility with nausea and vomiting. His past medical history included hypertension and hepatitis C with no history of fractures or kidney disease. Physical examination was normal. Upon admission the patient was afebrile with blood pressure of 170/120 mmHg and heart rate of 62 bpm. Chemistry showed Calcium of 14.5 mg/dL (8.6–10.2mg/dL), phosphorus 2.2 (2.7–4.5) mh/dL, magnesium 1.8 (1.7–2.6)mg/dL, intact PTH of 375 (15–65) pg/mL, PTH-related peptide <2.0 pmol/L(<2 pmol/L), 25-OH vitamin D of 19 ng/ml (30–80), Creatinine 1.22 (0.7–1.2)mg/dL, alkaline phosphatase 95 (40–129) units/L. He was started on aggressive hydration, calcitonin 4 units/kg, 4 mg of IV Zolendroninc acid. Neck sonogram revealed a large, complex, predominantly anechoic lesion with solid vascular components and thick internal septations in the inferior and medial aspect of the right thyroid lobe measuring 3 x 2 x 5.5 cm. Findings were confirmed with CT of the neck. Since Sestamibi scan (planar and SPECT/CT) did not show uptake in parathyroid glands, the cyst was thought to be of thyroid origin. Fine needle aspiration was not able to detect cellular material, but PTH was >100 pg/ml on the FNA sample. Otolaryngology service was consulted for parathyroidectomy. During the surgical treatment, the right upper parathyroid gland was removed with no changes in serum PTH. Next, the cystic lesion was removed with normalization of serum PTH (from 218 pg/ml to 35.2 pg/ml respectively). Intraoperative frozen section analysis was read as a cystic parathyroid adenoma. The final pathology report revealed cystic parathyroid tissue favoring parathyroid adenoma with focal atypia. Hypercalcemia resolved. Conclusions: Atypical cystic parathyroid adenomas are a rare cause of PHPT. 90% of parathyroid cysts are nonfunctional. Above mention is a case of a patient presenting with hypercalcemic crisis secondary to cystic parathyroid adenoma, which posed a diagnostic challenge as both neck ultrasound and 99mTc sestaMIBI scan were inconclusive. These findings should trigger suspicion for functional parathyroid lesions. Cystic components should be evaluated for PTH levels and if significantly elevated should be treated as a parathyroid adenoma.


2014 ◽  
Vol 33 (2) ◽  
pp. 93-98 ◽  
Author(s):  
I. Martínez-Rodríguez ◽  
N. Martínez-Amador ◽  
M. de Arcocha-Torres ◽  
R. Quirce ◽  
F. Ortega-Nava ◽  
...  

2012 ◽  
Vol 37 (3) ◽  
pp. 223-228 ◽  
Author(s):  
Renaud Ciappuccini ◽  
Julia Morera ◽  
Pierre Pascal ◽  
Jean-Pierre Rame ◽  
Natacha Heutte ◽  
...  

2012 ◽  
Vol 33 (10) ◽  
pp. 1070-1076 ◽  
Author(s):  
Babak Shafiei ◽  
Samaneh Hoseinzadeh ◽  
Fereidoun Fotouhi ◽  
Hadi Malek ◽  
Fereidoun Azizi ◽  
...  

Author(s):  
I. Martínez-Rodríguez ◽  
N. Martínez-Amador ◽  
M. de Arcocha-Torres ◽  
R. Quirce ◽  
F. Ortega-Nava ◽  
...  

2021 ◽  
Author(s):  
Albena Dimitrova Botushanova ◽  
Nikolay Petrov Botushanov

The visualization of abnormal parathyroid glands is difficult due to their variations in number and localization. Noninvasive parathyroid imaging studies include 99mTc-sestamibi scintigraphy, ultrasonography, computed tomography scanning, magnetic resonance imaging, and positron emission tomography. There is a general consensus that the most sensitive and specific imaging modality, especially when it is combined with single-photon emission CT is the scintigraphy with 99mTc-sestamibi or 99mTc-tetrofosmin. 99mTc-sestamibi scintigraphy significantly increases the role of preoperative scintigraphy in patients with hyperparathyroidism and allows unilateral surgical approach with minimally invasive parathyroidectomy to be used. Generally, three protocols with the use of two radiopharmaceuticals, 99mTc-sestamibi or 99mTc-tetrofosmin, are most widely applied: single-phase dual-isotope subtraction, dual-phase single-isotope and combination of both. Each one of them has specific advantages and disadvantages. While single parathyroid adenomas are localized with greater precision, hyperfunctioning parathyroid hyperplastic cells represent a real challenge to the imaging modalities. Several factors can influence the radionuclide uptake in pathologically changed parathyroid cells, like the size, the level of their functional activity, the quantity of oxyphilic cells, mitochondria, P glycoprotein and other MDR gene products.


2007 ◽  
Vol 35 (4) ◽  
pp. 186-190 ◽  
Author(s):  
Ilaria Grosso ◽  
Antonella Sargiotto ◽  
Patrizia D'Amelio ◽  
Cristina Tamone ◽  
Guido Gasparri ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document